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Silvery gray hair syndromes consist of three conditions: Chediak–Higashi syndrome (CHS), Griscelli syndrome (GS), and Elejalde syndrome (ES). All these three 
disorders are rare autosomal recessive disorders presenting in 
childhood. All the three conditions present with similar skin 
and hair changes but differ with respect to immunological 
and neurological manifestations. These disorders are often 
fatal in childhood as a result of accelerated phase. Therefore, 
only a few patients live to adulthood. CHS and GS Type II 
predominantly present with immune dysfunction which may 
progress to hemophagocytic lymphohistiocytosis (HLH) in 
the absence of treatment [1]. CHS, GS Type I, and ES patients 
who live to adulthood have severe crippling neurological 
manifestations while GS Type III patients have only skin 
and hair changes without any immunological or neurological 
manifestations leading to their underdiagnosis [2]. Microscopic 
examination of the hair shaft and peripheral smear examination 
is diagnostic. Stem cell transplantation is the only curative 
treatment.
This study was undertaken to increase the awareness about 
these rare disorders. Till now, no comprehensive study has 
been undertaken to analyze these spectra of disorders in our 
country. We would like to highlight that these disorders can be 
easily diagnosed by a thorough clinical examination and simple 
investigations which will enable us to make an early diagnosis, 
improve the prognosis by initiating early treatment.
METHODS
A total of 17 children diagnosed with silvery gray hair syndrome 
over a period of 10 years (2006-2015) from Inpatient and Outpatient 
Departments of Indira Gandhi Institute of Child Health, Bengaluru 
were studied retrospectively. All the case files were retrieved, 
and all the relevant clinical details as well as the investigation 
findings were recorded. Complete blood count was done using 
Mindray BC-5200 5 part differential cell counter, and peripheral 
blood smear examination which was done to look for prominent 
granules in the leukocytes was taken into account. Biochemical 
investigations, done using fully automated Beckman Coulter 
analyzer AU480, were also analyzed. Hair shaft was examined 
by light microscopy to look for the melanin pigment distribution. 
Serum immunoglobulin levels, cytological, biochemical, and 
microbiological examination findings, whenever available, were 
also taken into account. Ultrasound scan, computed tomography 
(CT), and magnetic resonance imaging (MRI) findings which 
were mentioned in the case file were also noted. Statistical 
analysis was done by generating univariate frequency tables for 
the parameters.
RESULTS
A total of 17 children were studied. The age of the children ranged 
from 5 months to 8 years. Sex ratio observed was male:female=1:4. 
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All the children were born out of consanguineous marriage except 
one. All the children were born at term with delayed milestones 
in one of them. Out of 17 children, two of them were siblings 
(Fig. 1). Clinical features of all the children have been summarized 
in Table 1, and as it is clearly evident from the table, most of the 
children presented with symptoms of infection.
Eight out of 17 children had pancytopenia. Peripheral smear 
examination in five children showed prominent granules in the 
leukocytes suggestive of CHS. Bone marrow (BM) examination 
was done in all the children, out of which four each of CHS 
and GS showed features of hemophagocytic syndrome. In four 
children with CHS, BM also showed giant granules in myeloid 
series cells and in eosinophils. Hair shaft examination in all 
the children showed irregular large clumps of melanin, and in 
Table 1: Clinical manifestations of the children in the study
Clinical features No of children
Silvery gray hair 17
Fever and recurrent respiratory tract infections 15
Multiple furunculosis 4
Hepatosplenomegaly 8
Bleeding diathesis 5
Ocular findings 5
Failure to thrive 3
Neurological symptoms 1
children with GS, the clumps were much larger in size than those 
in CHS (Fig. 2).
CT and MRI were done in all the patients. Out of 10 cases of 
GS Type II, CT and MRI findings were normal in three children. 
In the remaining seven children, CT and MRI showed variable 
findings. In CT scan, two of them had findings suggestive 
of calcification (Fig. 3) and five children revealed findings 
suggestive of atrophy and cell infiltration (Fig. 4). MRI revealed 
areas of increased T2 signal intensity and abnormal enhancement 
in the subcortical white matter. CT and MRI findings were normal 
in one case of GS III. Out of five children with CHS, CT and MRI 
findings were normal in one case, and in remaining four cases, 
findings were suggestive of diffuse brain atrophy. In ES, CT scan 
revealed abnormal findings in the white matter, cerebellum, and 
gray matter with atrophy of the brain and MRI showed marked 
cerebellar atrophy. Summary of the investigations has been listed 
in Table 2.
Clinical diagnosis was made at the time admission on the 
basis of the clinical findings and laboratory investigations. It 
was found that GS Type II is the most common entity in the 
spectrum of silvery gray hair syndromes, followed by CHS, 
GS Type III, and ES as depicted in Table 3. Out of five children 
Figure 1: Two siblings with Griscelli syndrome Type III
Figure 3: CT Brain (Plain) showing small calcification in the left 
basal ganglion region with mild ventricular dilatation
Figure 2: Microphotograph of the hair shaft showing irregular 
clumps of melanin in CHS & GS (X100)
ba
Figure 4: CT Brain (Plain) showing diffuse cerebral atrophy with 
mild ventricular dilatation
Vol 4 | Issue 2 | Apr - Jun 2017 Indian J Child Health 195
Hemalata et al. Silvery grey hair syndromes
with CHS, two succumbed to recurrent infections and three were 
lost to follow-up. However, out of 10 children with GS Type II, 
four had presented in accelerated phase and were treated with 
immunosuppressive agents. Unfortunately, even with aggressive 
management, one child succumbed to infection and the other three 
children were lost to follow-up after discharge from the hospital. 
Rest of the six children with GS Type II are on regular follow-up 
and are being treated with antibiotics and antiviral agents as and 
when symptomatic. One child with ES is on regular follow-up 
with symptomatic treatment. All the clinical features along with 
clinical diagnosis and management have been depicted in Table 4.
DISCUSSION
CHS is known to affect multiple systems of the body and is 
acquired by autosomal recessive inheritance. CHS is caused by 
mutations in a single gene characterized in 1996 as the lysosomal 
trafficking regulator localized to 1q42-43. To date, 40 mutations 
have been identified in the gene which include missense and 
nonsense mutations and small deletions and insertions in the 
coding region [3,4]. Throughout the world, <500 cases of CHS 
have been reported over the past 20 years [5,6]. 15 patients were 
diagnosed during a period of 11 years (2000-2010) in a nation-
wide survey in Japan, indicating that one or two patients with 
CHS were diagnosed each year. There are only a few case reports 
from India [7-9].
Symptoms of CHS usually appear soon after birth or in children 
younger than 5 years, and the mean age of onset is 5.85 years. 
However, most of the patients die before the age of 10 years. 
In our study, the earliest age of presentation was 5 months, and 
the mean age was 2.68 years. Out of five children with CHS, 
four presented in the accelerated phase and two succumbed to 
Table 2: Investigation findings in the study group
Investigations No of children
Pancytopenia on peripheral smear 8
Prominent granules in leukocytes 5
BM showing hemophagocytosis 8
Hair shaft showing irregular clumps 17
CT, MRI abnormality 12
CT: Computed tomography, MRI: Magnetic resonance imaging, BM: Bone marrow
Table 3: Final diagnosis in the spectrum of silvery gray hair 
syndrome
Silvery gray hair syndrome No of children (%)
Chediak–Higashi syndrome 5 (29.5)
GS-I 0 (0)
GS-II 10 (58.9)
GS-III 1 (5.8)
ES 1 (5.8)
Total 17
GS: Griscelli syndrome, ES: Elejalde syndrome
Table 4: Clinical diagnosis and management of children with silvery gray hair syndrome
Age Gender H/O 
consanguinity
Immunodeficiency Neurological 
manifestations
Cytoplasmic 
inclusions
Hair shaft 
examination- 
clumps
Hemophagocytosis Diagnosis Outcome
8 years Male Yes No No No Large No GS III Follow-up
1 years Female No Yes No No Large No GS II Follow-up
6 months Female Yes Yes Yes No Large Yes GS II Follow-up
5 years Male Yes Yes Yes No Large Yes GS II Died
3 years Female Yes Yes Yes Yes Small Yes CHS Died
1 years  
6 months
Female Yes Yes No No Large No GS II Follow-up
1 years Male Yes Yes Yes No Large Yes GS II Follow-up
2 years  
7 months
Male Yes Yes Yes No Large Yes GS II Lost to 
follow-up
6 months Male Yes Yes No No Large No GS II Lost to 
follow-up
7 years Female Yes Yes Yes No Large No GS II Follow-up
11 months Male Yes No Yes No Large No ES Follow-up
11 months Male Yes Yes Yes No Large No GS II Lost to 
follow-up
10 months Female Yes Yes Yes No Large No GS II Follow-up
5 years Male Yes Yes No Yes Small No CHS Lost to 
follow-up
2 years Female Yes Yes Yes Yes Small Yes CHS Died
5 months Male Yes Yes Yes Yes Small Yes CHS Lost to 
follow-up
3 years Male Yes Yes Yes Yes Small Yes CHS Lost to 
follow-up
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the infection. Other three children were lost to follow-up. In our 
cases, unique finding was solitary giant cytoplasmic inclusion 
noted predominantly in the lymphocytes (Fig. 5), which is a rare 
occurrence. This is in contrast to the usual finding of the presence 
of such inclusion predominantly in the myeloid series cells and 
less commonly in the lymphocytes, according to the literature 
review.
Frequent bacterial infections and hemophagocytic syndrome 
are the major causes of morbidity. Fatal hemophagocytic syndrome 
is seen in 50-80% of patients with CHS, if untreated, which is also 
termed as accelerated phase. If BM transplantation is not carried 
out, most of the patients may die of hemophagocytic syndrome, 
but few patients may have relatively milder disease. Neurological 
manifestations such as polyneuropathy, parkinsonism, dementia, 
and ataxia characterize the adult form of CHS which is milder. 
CHS should be suspected in young adults, with a combination 
of these defects with oculocutaneous albinism or recurrent 
infections. A peripheral smear finding of giant inclusion in the 
leukocytes is diagnostic [10].
GS is a rare disorder acquired due to autosomal recessive 
inheritance, which results in pigmentary dilution of the skin 
and hair (silver hair) with the presence of large clumps of 
pigment in hair shafts and an accumulation of melanosomes in 
melanocytes [11]. Overall, three types of GS have been described 
based on clinical features and genetic mutations [12]. GS Type I 
manifests with primary dysfunction of central nervous system 
(CNS) characterized by Myosin Va mutation [13]. GS Type II 
commonly manifests with immunological abnormalities and 
develops HLH and is characterized by a defect in the Rab27a 
gene [14-16]. In HLH, T-lymphocytes and macrophages proliferate 
and infiltrate most of the organs, including the brain, leading to 
mortality. This immune abnormality can initially be controlled 
with immunosuppressive treatment, but stem cell transplantation 
is the only definitive curative treatment for this condition [17]. In 
GS Type II patients, the inability of lymphocytes and natural killer 
cells to lyse target cells is due to inability to consistently secrete 
the cytotoxic granules accounting for the severe immunological 
disorder, namely HLH [18]. GS Type III patients manifest with 
merely partial albinism with a defect in melanophilin gene [19].
In our study, a maximum number of children belonged to GS 
Type II, most of them had fever and upper respiratory tract infections, 
and one had pneumonia. 4 out of 10 had hepatosplenomegaly and 
BM examination revealed hemophagocytic syndrome. All four 
of them were recommended BM/stem cell transplantation, out 
of which one succumbed to infection and the others were lost 
to follow-up. One child who was diagnosed to have GS Type III 
was incidentally identified by noting her silvery gray hair and 
hypopigmented skin. The diagnosis was confirmed through hair 
shaft examination by light microscopy. This child did not have 
any neurological or immunological manifestations.
Very few cases of GS have been reported so far from all 
over the world. Most reported cases are from the Turkish and 
Mediterranean population. However, in 2004, Manglani et al. [20] 
and Rath et al. [21] reported several cases from India. In most of 
the patients, diagnosis was done between the ages of 4 months 
and 7 years with the youngest occurring at 1 month [22]. In 
our study, diagnosis was made between the ages 6 months and 
9 years. Rajyalakshmi and Chakrapani [23] have reported a case 
of GS Type II in a 4-year-old South Indian boy who presented 
in accelerated phase with features of immunodeficiency and 
secondary neurological manifestations caused by the involvement 
of the brain and also demonstrated lymphohistiocytosis in the 
lymph nodes. Verma et al. [24] have reported GS Type II in a 
17-month-old boy who incidentally presented with severe anemia, 
which was due to parvovirus B19 infection, suggested by BM 
findings and later confirmed by DNA polymerase chain reaction.
ES was first described in 1977 [25]. It is also referred to as 
neuroectodermal melanolysosomal disease. It has been suggested 
that ES is the same disease entity as GS Type I which is caused by 
Myo Va gene mutation [26]. Still, the exact basis for ES remains 
to be defined [27]. Certain clinical features such as very early 
onset of neurological symptoms such as severe mental retardation, 
seizures, and severe hypotonia and tendency for intense tanning 
after exposure to the sun are used in differentiating GS Type I and 
ES. However, gene mutation specific to ES is yet to be defined [28]. 
ES is an autosomal recessive disease characterized by silvery hair 
and CNS dysfunction. Severe neurologic impairment either is 
congenital or develops during childhood. However, the function 
of the immune system is not impaired. ES is also featured by a 
wide spectrum of ophthalmologic abnormalities. Microscopic 
examination of the hair shaft reveals large granules of melanin 
which are unevenly distributed. Abnormal melanocytes, 
melanosomes, and abnormal inclusion bodies may be present in 
fibroblasts [29].
In the present study, only one child was diagnosed to have 
ES based on the clinical features of silvery gray hair, eyebrows 
and eyelashes, delayed milestones, and seizures at the age of 
11 months. There was no immunological abnormality. CT and 
MRI findings were also supportive, and the child is on regular 
follow-up. The findings of hair shaft examination in CHS were 
the presence of uneven accumulation of large pigment granules. 
In GS, the hair shaft examination also revealed irregular large 
pigment granules, but relatively the size of pigment granules was 
larger compared to CHS. Sheela et al. [30] have also found that 
in GS, the size of clusters of melanin pigment is six times larger 
than in CHS. A skin biopsy specimen can be normal or may show 
Figure 5: Microphotograph of the peripheral smear showing 
cytoplasmic inclusion in the lymphocyte (Leishman stain, X100)
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large melanin deposits and sparse dermal melanin.
The distinguishing feature of CHS on peripheral smear 
examination is the presence of giant intracytoplasmic granules in 
all granulated cells which is not seen in GS [31]. Although all 
the three silvery gray hair syndromes manifest with overlapping 
clinical and genetic findings, Table 5 helps in the differential 
diagnosis. Examination of hair from fetal scalp biopsy specimen 
and microscopic examination of the leukocytes from fetal blood 
samples aid in the prenatal diagnosis of silvery gray hair syndrome. 
Allogenic BM transplant/hematopoietic stem cell transplant is 
the only curative treatment, when done early, before the onset of 
HLH. Otherwise, the management is largely symptomatic. Once 
HLH develops, it is fatal [32,33]. There is also scope for prenatal 
diagnosis and counseling for these rare disorders.
Limitations of our study were its retrospective design and a 
small number of the patients. Second, we could not confirm the 
diagnosis by genetic analysis due to non-availability of the facility 
in our institution. Similarly, none of the patients underwent 
hematopoietic stem cell transplant as it was not available in our 
institution, and patients could not be taken up to higher center 
despite advice being given for the same.
CONCLUSION
We present the spectrum of silvery gray hair syndromes with 
their characteristic clinical and diagnostic findings in a tertiary 
care pediatric institute. The characteristic silvery gray hair of 
the patients is emphasized so that it is quite possible to suspect 
the diagnosis at the bedside and easily diagnosed by simple 
laboratory investigations such as hair shaft and peripheral smear 
examination.
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